S. Godoy‐Tundidor

发表

2,2-Bis(4-Chlorophenyl)-1,1-Dichloroethylene Stimulates Androgen Independence in Prostate Cancer Cells through Combinatorial Activation of Mutant Androgen Receptor and Mitogen-Activated Protein Kinase Pathways

K. Knudsen, Y. Daaka, J. K. Hess-Wilson, 2008, Molecular Cancer Research.

Influence of the in situ component in 389 infiltrating ductal breast carcinomas

I. Zapardiel, S. Godoy-Tundidor, I. Rodríguez‐García, 2013, Breast Cancer.

The transcriptional co-activator cAMP response element-binding protein-binding protein is expressed in prostate cancer and enhances androgen- and anti-androgen-induced androgen receptor function.

H. Klocker, G. Bartsch, A. Hobisch, 2003, The American journal of pathology.

Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.

H. Klocker, D. Fuchs, G. Bartsch, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.

F. Claessens, K. Knudsen, C. Comstock, 2008, Cancer research.

Progesterone induces Apoptosis in TRAIL‐resistant ovarian cancer cells by circumventing c‐FLIPL overexpression

S. Ho, Kasturi Mukherjee, V. Syed, 2007, Journal of cellular biochemistry.

Evaluation of Endometrial and Subendometrial Vascularization and Endometrial Volume by 3-D Power Doppler Ultrasound and Its Relationship with Age and Pregnancy in Intrauterine Insemination Cycles

I. Zapardiel, T. Pérez-Medina, S. Godoy-Tundidor, 2011, Gynecologic and Obstetric Investigation.

Prostate cancer cells generated during intermittent androgen ablation acquire a growth advantage and exhibit changes in epidermal growth factor receptor expression

G. Bartsch, E. Artner-Dworzak, A. Hobisch, 2004, The Prostate.

Acquisition of agonistic properties of nonsteroidal antiandrogens after treatment with oncostatin M in prostate cancer cells.

G. Bartsch, A. Hobisch, Z. Culig, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Androgen Receptor and Interleukin-6 Signaling In PCA Progression

G. Bartsch, A. Hobisch, Z. Culig, 2005 .

Interleukin‐6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen‐activated protein kinase and phosphatidylinositol 3‐kinase

D. Fuchs, G. Bartsch, K. Friedbichler, 2005, The Prostate.

An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6.

G. Bartsch, H. Lilja, A. Bjartell, 2004, European journal of cancer.

Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway.

D. Fuchs, G. Bartsch, A. Berger, 2003, The American journal of pathology.

Concurrent puerperal hysterectomy with Ascaris lumbricoides infestation: coincidence or consequence?

I. Zapardiel, S. Godoy-Tundidor, M. Peiretti, 2010, American journal of obstetrics and gynecology.

Transcriptome Analyses in Normal Prostate Epithelial Cells Exposed to Low-Dose Cadmium: Oncogenic and Immunomodulations Involving the Action of Tumor Necrosis Factor

M. Medvedovic, R. Cheng, S. Ho, 2008, Environmental health perspectives.